Pricing Log in Create free account

DexCom, Inc. (DXCM) vs Smith & Nephew SNATS, Inc. (SNN)

DexCom, Inc. and Smith & Nephew SNATS, Inc. are both Medical Devices companies. DexCom, Inc. is the larger, with a market value of $31.5B against $13.4B — 2.4× the size. DexCom, Inc. trades at the lower P/E: 32.6× against 38.9×. DexCom, Inc. grew revenue faster over the last twelve months: 13.0% against 4.81%. DexCom, Inc. has the higher net margin (19.4% vs 6.71%) and the higher return on invested capital (39.0% vs 0.00%). Across the 22 metrics below, DexCom, Inc. leads on 13 and Smith & Nephew SNATS, Inc. on 9.

Valuation

Metric DXCM SNN Medical Devices median
P/E 32.61 38.94 25.58
P/S 6.20 1.37 2.54
P/B 12.48 2.77 2.48
Price to free cash flow 28.81 7.09 28.81
EV/EBITDA 21.24 6.54 11.51
EV/Sales 6.24 1.60 2.72
Earnings yield 3.07% 2.57% (12.82%)
Free cash flow yield 3.47% 14.10% (8.18%)

Profitability

Metric DXCM SNN Medical Devices median
Gross margin 63.42% 70.52% 57.76%
Operating margin 23.98% 0.00% (15.07%)
Net margin 19.41% 6.71% (14.45%)
Free cash flow margin 21.52% 0.00% (3.88%)
Return on equity 37.67% 0.00% (10.35%)
Return on assets 14.43% 0.00% (17.26%)
Return on invested capital 39.00% 0.00% (5.27%)

Growth

Metric DXCM SNN Medical Devices median
Revenue growth (TTM) 13.03% 4.81% 10.41%
EPS growth (last fiscal year) 47.18% 52.34% 28.17%
Revenue growth, 5-year CAGR 19.33% 6.21% 15.74%
Net income growth, 5-year CAGR 8.75% 6.89% 0.00%

Health

Metric DXCM SNN Medical Devices median
Debt to equity 0.49 0.62 0.04
Current ratio 1.74 2.14 2.74
Net debt to EBITDA (0.65) 1.92 0.54

Dividend

Metric DXCM SNN Medical Devices median
Dividend yield — 2.49% 1.02%
Payout ratio — — 0.37

Size

Metric DXCM SNN Medical Devices median
Market cap 31.50b 13.40b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack